Patients using Argus II report improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant, popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by Retinitis Pigmentosa (RP), a rare, degenerative eye disease. The findings show that the Argus II significantly improves visual function and quality of life for people blinded by RP.

Will the brain be able to fully adapt to treatment of blindness?

A partial restoration of sight is possible in individuals blind from birth, thanks to the most recent advances in research. However, a group of researchers of the Mind/Brain Center of the University of Trento and of the University of Montréal in Canada have discovered that the functional reorganization of the brain happens in individuals who, for a long period, experienced a long sense deprivation, which could potentially impede complete sight restoration.

Nanotechnology breakthrough will lead to a better artificial retina for visually impaired

(c) American Chemical Society

 
Scientists from Hebrew University of Jerusalem researchers in collaboration with colleagues from Tel Aviv University and Newcastle University, have developed a new light-sensitive film that could one day form the basis of a prosthetic retina to help people suffering from retinal damage or degeneration.